• 1 *HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; †Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; ‡The Kirby Institute, Faculty of Medicine, University of New South Wales, Sydney, Australia; §Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ‖YRG Centre for AIDS Research and Education, Chennai, India; ¶Queen Elizabeth Hospital, Hong Kong, China; #Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; **Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand; ††Hospital Sungai Buloh, Kuala Lumpur, Malaysia; ‡‡University of Malaya, Kuala Lumpur, Malaysia; §§Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia; ‖‖Research Institute for Tropical Medicine, Manila, Philippines; ¶¶Faculty of Medicine, Udayana University and Sanglah Hospital, Bali, Indonesia; ##Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; ***TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand; and †††Brown University Alpert Medical School, Providence, RI
J. Acquir. Immune Defic. Syndr., 2014 May 1;66(1):74-9.
PMID: 24413039 DOI: 10.1097/QAI.0000000000000108


We compared treatment outcomes of transmitted drug resistance (TDR) in patients on fully or partially sensitive drug regimens.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.